Daniel A. Arber, M.D.
Publication Details
-
The prognostic value of CXCR4 in acute myeloid leukemia.
Appl Immunohistochem Mol Morphol. 2013; (1): 79-84
CXC chemokine receptor (CXCR4) has been shown to be expressed in a subset of acute myeloid leukemia (AML) patients and is correlated with a poor prognosis. CXCR4 expression appears to be an independent prognostic factor for survival in a heterogeneous group of AML patients. To better assess its significance, we analyzed CXCR4 expression in a group of AML patients.
Help
Trial Administration